Manhattan Scientifics, Inc. (MHTX)

[ssc]

Already in May and no one enrolled in the first trial. Looks like another year (at least) has been added to this long overdue "moonshot". And this trial doesn't even include the human machine which has yet to be designed and developed. Remember the "excellent dd" that said the human machine was completed long ago? All the misinformation only highlights the problems with ibx and mhtx.

Now another new collaboration with no mention of costs, development time, or anything else that might support the ibx share price which is now less than half of the original ipo price instead of $.44 as recently predicted. Sad joke.